A Two-Cohort, Randomised Sequence, Cross-over, Open-label Study to Assess the Effect of a Single Dose of Sodium Zirconium Cyclosilicate (SZC) on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
Latest Information Update: 09 Apr 2024
At a glance
- Drugs Zirconium silicate (Primary) ; Ciclosporin; Tacrolimus
- Indications Hyperkalaemia
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 21 Sep 2021 Status changed from active, no longer recruiting to completed.
- 03 Sep 2021 Planned End Date changed from 19 Aug 2021 to 16 Sep 2021.
- 03 Sep 2021 Planned primary completion date changed from 19 Aug 2021 to 16 Sep 2021.